论文部分内容阅读
恶性腹水是肿瘤发展到晚期常见的并发症,是降低患者生活质量的主要因素之一,因此控制腹水快速生长或消除腹水在晚期肿瘤综合治疗中显得尤为重要。在全身治疗无效时,腹腔化疗仍有较好的效果。我科于1999～2001年,对晚期肿瘤病人采用腹腔灌注羟基喜树碱治疗恶性腹水患者36例,取得
Malignant ascites is a common complication of advanced tumor development and is one of the main factors to reduce the quality of life of patients. Therefore, it is particularly important to control the rapid growth of ascites or eliminate ascites in the treatment of advanced cancer. In the case of systemic therapy is invalid, intraperitoneal chemotherapy is still a good effect. In our department from 1999 to 2001, 36 cases of malignant ascites were treated by peritoneal perfusion of hydroxycamptothecin in advanced cancer patients.